Creative Planning Merck & Co., Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Merck & Co., Inc. stock. As of the latest transaction made, Creative Planning holds 842,472 shares of MRK stock, worth $82.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

842,472

Previous 867,203 2.85%

Holding current value

$82.1 Million

Previous $107 Million 10.89%

% of portfolio

0.1%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$111.15 - $128.97 $2.75 Million - $3.19 Million	-24,731 Reduced 2.85%	842,472 $95.7 Million
Q2 2024 Aug 15, 2024	BUY	$123.8 - $132.96 $5.03 Million - $5.41 Million	40,668 Added 4.92%	867,203 $107 Million
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $4.47 Million - $5.21 Million	39,464 Added 5.01%	826,535 $109 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $10.6 Million - $11.6 Million	-106,168 Reduced 11.89%	787,071 $85.8 Million
Q3 2023 Nov 16, 2023	BUY	$102.95 - $114.33 $19.9 Million - $22.1 Million	193,564 Added 27.66%	893,239 $92 Million
Q2 2023 Jul 21, 2023	BUY	$108.61 - $118.38 $1.97 Million - $2.15 Million	18,146 Added 2.66%	699,675 $80.7 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $848,328 - $946,561	8,241 Added 1.22%	681,529 $72.5 Million
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $432,478 - $554,496	-4,946 Reduced 0.73%	673,288 $74.7 Million
Q3 2022 Nov 03, 2022	SELL	$84.53 - $94.96 $1.15 Million - $1.29 Million	-13,632 Reduced 1.97%	678,234 $58.4 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $3.09 Million - $3.5 Million	36,957 Added 5.64%	691,866 $63.1 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $14.5 Million - $16.2 Million	196,813 Added 42.96%	654,909 $53.7 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $1.56 Million - $1.95 Million	-21,551 Reduced 4.49%	458,096 $35.1 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $3.58 Million - $3.94 Million	49,967 Added 11.63%	479,647 $36 Million
Q2 2021 Aug 04, 2021	SELL	$70.31 - $77.77 $868,539 - $960,692	-12,353 Reduced 2.79%	429,680 $33.4 Million
Q1 2021 Apr 30, 2021	SELL	$68.86 - $81.11 $226,549 - $266,851	-3,290 Reduced 0.74%	442,033 $34.1 Million
Q4 2020 Jan 29, 2021	BUY	$71.77 - $79.65 $1.41 Million - $1.57 Million	19,666 Added 4.62%	445,323 $36.4 Million
Q3 2020 Nov 05, 2020	BUY	$73.18 - $82.95 $1.7 Million - $1.93 Million	23,230 Added 5.77%	425,657 $35.3 Million
Q2 2020 Jul 23, 2020	BUY	$70.42 - $80.13 $1.3 Million - $1.48 Million	18,420 Added 4.8%	402,427 $31.1 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $1.34 Million - $1.86 Million	-21,217 Reduced 5.24%	384,007 $29.5 Million
Q4 2019 Jan 30, 2020	BUY	$77.58 - $87.54 $1.03 Million - $1.16 Million	13,288 Added 3.39%	405,224 $36.9 Million
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $3,804 - $4,146	50 Added 0.01%	391,936 $33 Million
Q2 2019 Jul 26, 2019	BUY	$69.84 - $81.59 $471,839 - $551,222	6,756 Added 1.75%	391,886 $32.9 Million
Q1 2019 Apr 24, 2019	BUY	$69.58 - $79.36 $11,759 - $13,411	169 Added 0.04%	385,130 $32 Million
Q4 2018 Feb 01, 2019	BUY	$65.24 - $75.71 $1.8 Million - $2.09 Million	27,540 Added 7.71%	384,961 $29.4 Million
Q3 2018 Oct 25, 2018	BUY	$57.69 - $67.84 $1.79 Million - $2.11 Million	31,031 Added 9.51%	357,421 $25.4 Million
Q2 2018 Jul 20, 2018	BUY	$50.83 - $59.72 $495,287 - $581,911	9,744 Added 3.08%	326,390 $19.8 Million
Q1 2018 Apr 18, 2018	SELL	$50.96 - $59.23 $468,424 - $544,442	-9,192 Reduced 2.82%	316,646 $17.2 Million
Q4 2017 Jan 17, 2018	BUY	$51.62 - $61.64 $295,782 - $353,197	5,730 Added 1.79%	325,838 $18.3 Million
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $18.8 Million - $20.2 Million	320,108	320,108 $20.5 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Merck & Co., Inc. Transaction History